Loading...
•
Jan 03
Plexus Q1 2026 Earnings Report
Plexus reported solid results for Q1 2026, with revenue hitting $1.07 billion and adjusted EPS reaching $1.78.
Key Takeaways
Plexus delivered a strong Q1 2026, meeting revenue guidance and achieving the high end of adjusted EPS expectations. Growth was driven by Healthcare/Life Sciences and Aerospace/Defense sectors. However, free cash flow was negative due to working capital investments for new program ramps.
Revenue reached $1.07 billion, up 10% YoY.
Adjusted EPS was $1.78, at the high end of guidance.
Net income totaled $41.2 million.
Free cash flow was negative $50.6 million due to program ramp investments.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Plexus expects continued sequential revenue growth in Q2 2026, supported by new program ramps and improved end-market demand.
Positive Outlook
- Revenue guidance for Q2 set at $1.110 to $1.150 billion.
- Non-GAAP EPS guidance of $1.80 to $1.95.
- Anticipated revenue growth of 6% sequentially and 15% YoY.
- Strong demand from Healthcare/Life Sciences and Aerospace/Defense sectors.
- Continued investments in technology and capabilities.
Challenges Ahead
- Free cash flow expected to remain under pressure in early 2026.
- Cash cycle elevated due to working capital investments.
- Stock-based compensation impacting GAAP margins.
- Economic return declined from prior quarter.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...